Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Financial Results

Rhea-AI Summary

Tenon Medical, Inc. (TNON) to release financial results for Q4 and full year 2023 on March 12, 2024. Conference call scheduled for analysts and investors.

LOS GATOS, CA / ACCESSWIRE / February 27, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced plans to release financial results for the fourth quarter and full year 2023 ended December 31, 2023 after market close on Tuesday, March 12, 2024. The Company will also hold a conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.

Date:	Tuesday, March 12, 2024
Time:	4:30 p.m. Eastern time
Dial-in:	1-877-407-0792
International Dial-in:	1-201-689-8263
Webcast:	TNON Conference Call

Please dial in at least 10 minutes before the start of the call to ensure timely participation.

An audio playback of the call will be available through March 26, 2024, on Tenon's Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921(USA) or 1-412-317-6671 (International). The access code will be 13744319.

About Tenon Medical, Inc.

Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022 Tenon is focused on three commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants and 3) SI Joint fusion adjunct to a spine fusion construct. For more information, please visit https://www.tenonmed.com/.

The Tenon Medical logo, Tenon Medical and Catamaran are registered trademarks of Tenon Medical, Inc.

Investor Contact
Shannon Devine
MZ North America
203-741-8811
tenon@mzgroup.us

SOURCE: Tenon Medical, Inc.

View the original press release on accesswire.com

FAQ

When will Tenon Medical, Inc. (TNON) release financial results for Q4 and full year 2023?

Tenon Medical, Inc. (TNON) will release financial results for the fourth quarter and full year 2023 on March 12, 2024.

What time is the conference call scheduled for Tenon Medical, Inc. (TNON) financial results discussion?

The conference call to discuss Tenon Medical, Inc. (TNON) financial results is scheduled for 4:30 p.m. Eastern Time on March 12, 2024.

How can I participate in the conference call for Tenon Medical, Inc. (TNON) financial results?

To participate in the conference call for Tenon Medical, Inc. (TNON) financial results, dial 1-877-407-0792 (USA) or 1-201-689-8263 (International) at least 10 minutes before the start of the call.

Where can I access the audio playback of the conference call for Tenon Medical, Inc. (TNON) financial results?

The audio playback of the conference call for Tenon Medical, Inc. (TNON) financial results will be available through March 26, 2024, on Tenon's Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671 (International) with access code 13744319.